UPMC is pursuing an ambitious deal to affiliate with Harrisburg-based PinnacleHealth System, according to two people familiar with the talks, potentially giving UPMC entry into a Central Pennsylvania market dominated by Blue Cross Blue Shield health insurance plans.
In a prepared statement, PinnacleHealth spokeswoman Kelly McCall said the system “and its board of directors continue to consider partnership models and strategic opportunities that would serve the best interests of our patients, local employers and other stakeholders.”
Following a period of affiliation, UPMC would acquire Pinnacle’s three-hospital system, which has 636 beds and employs 6,200 people, with the possibility of picking up as many as four smaller hospitals, people familiar with the transaction said.
UPMC is a $14 billion nonprofit enterprise that operates more than 20 hospitals, which are concentrated in Western Pennsylvania.
The deal with PinnacleHealth would be the biggest of its kind for UPMC and a first for the Pittsburgh health system if it is consummated in its entirety. Typically, UPMC has acquired one hospital at a time.
Full Content: Pittsburgh Post Gazette
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas